Search - tctmd.com

Displaying 681 - 700 of 736

Sort: Relevancy | Date

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

El Punto de Acceso Utilizado para las Cateterizaciones Cardíacas No Influye en la Exposición a la Radiación de los Pacientes

L.A. McKeown

July 27, 2015

News Daily News

Access Site Used for Cardiac Cath Does Not Influence Radiation Exposure for Patients

L.A. McKeown

July 27, 2015

News Industry News

HeartWare launches European trial for next-gen MVAD heart pump

July 20, 2015

News Daily News

La FDA Da la Voz de Alarma sobre el Uso del Dispositivo Lariat para el Cierre del AAI en Pacientes con FA

Yael L. Maxwell

July 17, 2015

News Daily News

FDA对在房颤患者中使用Lariat左心耳封堵装置发出警示

Yael L. Maxwell

July 17, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Industry News

Cardiovascular Systems Completes Coast Study Enrollment

July 14, 2015

News Daily News

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

Todd Neale

July 13, 2015

News Daily News

FDA批准了一种具有生存优势的心力衰竭药物

Todd Neale

July 13, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Industry News

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

June 22, 2015

News Daily News

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

L.A. McKeown

June 22, 2015

News Industry News

Medtronic announces financial investment in Arsenal AAA, LLC

June 17, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

June 16, 2015

News Industry News

Milestone Pharmaceuticals Closes US$17 Million Series B Financing to Complete Phase 2 Clinical Studies for MSP-2017

June 15, 2015

Advertisement

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

El Punto de Acceso Utilizado para las Cateterizaciones Cardíacas No Influye en la Exposición a la Radiación de los Pacientes

Access Site Used for Cardiac Cath Does Not Influence Radiation Exposure for Patients

HeartWare launches European trial for next-gen MVAD heart pump

La FDA Da la Voz de Alarma sobre el Uso del Dispositivo Lariat para el Cierre del AAI en Pacientes con FA

FDA对在房颤患者中使用Lariat左心耳封堵装置发出警示

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Cardiovascular Systems Completes Coast Study Enrollment

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

FDA批准了一种具有生存优势的心力衰竭药物

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

Medtronic announces financial investment in Arsenal AAA, LLC

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

Milestone Pharmaceuticals Closes US$17 Million Series B Financing to Complete Phase 2 Clinical Studies for MSP-2017

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content